Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial - Patrikidou, A; Chabaud, S; Ray-Coquard, I (Ann Oncol, 2013)
et al.